Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 percent. This is a 225 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $92.70 million which beat the analyst consensus estimate of $80.74 million by 14.81 percent. This is a 14.16 percent increase over sales of $81.20 million the same period last year.